We are live on ! Find out more
FC

Fore Capital Portfolio holdings

AUM $338M
1-Year Est. Return 10.07%
This Fund
S&P 500
This Quarter Est. Return
+0.81%
1 Year Est. Return
+10.07%
3 Year Est. Return
+25.37%
5 Year Est. Return
+23.47%
10 Year Est. Return
–
AUM
$294M
AUM Growth
+$99.4M
Cap. Flow
-$48.6M
Cap. Flow %
-16.51%
Top 10 Hldgs %
77.87%
Holding
65
New
15
Increased
5
Reduced
5
Closed
20

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$2.06M
2
SHC icon
Sotera Health
SHC
+$1.32M
3
SLV icon
iShares Silver Trust
SLV
+$1.08M
4
SNY icon
Sanofi
SNY
+$989K
5
SILC icon
Silicom
SILC
+$931K

Top Sells

Rank Stock Value
1
XDIV
U.S. Equity Ex-Dividends Fund - Series 2027
XDIV
+$14.5M
2
T icon
AT&T
T
+$1.89M
3
OGN icon
Organon & Co
OGN
+$1.48M
4
EQT icon
EQT Corp
EQT
+$1.02M
5
EPD icon
Enterprise Products Partners
EPD
+$673K

Sector Composition

Rank Sector Weight
1 Miscellaneous 96.33%
2 Healthcare 1.64%
3 Technology 0.81%
4 Materials 0.39%
5 Utilities 0.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLD icon
1
CALL
SPDR Gold Trust
GLD
$149B
$103M 34.87%
+600,000
New +$101M
SLV icon
2
CALL
iShares Silver Trust
SLV
$32.3B
$46.2M 15.72%
2,150,000
-742,200
-26% -$16M
HYG icon
3
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.6B
$34.8M 11.83%
+400,000
New +$34.7M
EPD icon
4
CALL
Enterprise Products Partners
EPD
$84.3B
$8.56M 2.91%
390,000
+140,000
+56% +$3.14M
WMB icon
5
CALL
Williams Companies
WMB
$90.2B
$7.81M 2.66%
300,000
+100,000
+50% +$2.76M
SNY icon
6
CALL
Sanofi
SNY
$107B
$4.01M 1.36%
+80,000
New +$3.96M
SILC icon
7
Silicom
SILC
$243M
$2.4M 0.81%
46,429
+21,000
+83% +$931K
AZN icon
8
AstraZeneca
AZN
$252B
$2.04M 0.69%
+17,500
New +$2.06M
MOS icon
9
CALL
The Mosaic Company
MOS
$7.5B
$1.97M 0.67%
+50,000
New +$1.91M
IDIV
10
DELISTED
U.S. Equity Cumulative Dividends Fund - Series 2027
IDIV
$1.95M 0.66%
191,605
-8,395
-4% -$84.8K
STNG icon
11
CALL
Scorpio Tankers
STNG
$3.91B
$1.54M 0.52%
+120,000
New +$1.85M
CHTR icon
12
PUT
Charter Communications
CHTR
$18.3B
$1.3M 0.44%
+2,000
New +$1.36M
WMB icon
13
PUT
Williams Companies
WMB
$90.2B
$1.3M 0.44%
50,000
-50,000
-50% -$1.38M
SHC icon
14
Sotera Health
SHC
$5.5B
$1.29M 0.44%
+55,000
New +$1.32M
AZN icon
15
CALL
AstraZeneca
AZN
$252B
$1.17M 0.4%
+10,000
New +$1.18M
SLV icon
16
iShares Silver Trust
SLV
$32.3B
$1.08M 0.37%
+50,000
New +$1.08M
SNY icon
17
Sanofi
SNY
$107B
$1M 0.34%
+20,000
New +$989K
VST icon
18
Vistra
VST
$46B
$897K 0.3%
39,409
+3,000
+8% +$60.2K
PLL
19
DELISTED
Piedmont Lithium
PLL
$787K 0.27%
+15,000
New +$878K
PLL
20
PUT
DELISTED
Piedmont Lithium
PLL
$787K 0.27%
+15,000
New +$878K
TE
21
T1 Energy
TE
$1.41B
$671K 0.23%
+60,000
New +$650K
EPD icon
22
Enterprise Products Partners
EPD
$84.3B
$439K 0.15%
20,000
-30,000
-60% -$673K
CCO icon
23
Clear Channel Outdoor Holdings
CCO
$1.19B
$435K 0.15%
131,524
– –
TMQ
24
Trilogy Metals
TMQ
$625M
$373K 0.13%
225,766
+30,000
+15% +$55.3K
BMRA icon
25
Biomerica
BMRA
$6.61M
$331K 0.11%
10,625
-6,250
-37% -$241K
1
2

Similar funds

EWA
Etesian Wealth Advisors West Linn, Oregon $338M AUM 15.5% 1-Year Est. Return
ECAM
East Coast Asset Management Essex, Massachusetts $339M AUM 36.71% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $339M AUM 120.53% 1-Year Est. Return
NIWA
New Insight Wealth Advisors San Ramon, California $339M AUM 28.36% 1-Year Est. Return
HFS
Haverford Financial Services Radnor, Pennsylvania $339M AUM 16.41% 1-Year Est. Return
CWM
Castle Wealth Management West Palm Beach, Florida $338M AUM 18.79% 1-Year Est. Return
BAM
Brilliance Asset Management Admiralty, Hong Kong, Hong Kong $339M AUM 8.73% 1-Year Est. Return
JWM
Jeppson Wealth Management Manhattan Beach, California $339M AUM 32.85% 1-Year Est. Return

Fore Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Fore Capital held 65 positions worth $294M, up 51% from $195M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Fore Capital withdrew a net $48.6M in Q4 2021, closing 20 positions and reducing 5 holdings. Its most notable exit was U.S. Equity Ex-Dividends Fund - Series 2027, an estimated $14.5M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 96% of assets, up from 95% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Fore Capital opened a new position in AstraZeneca worth $2.04M.

  • Fore Capital's largest Q4 2021 buy was AstraZeneca: 17,500 shares worth $2.04M.
  • Fore Capital added most to Silicom in Q4 2021, an estimated $931K increase.
  • Fore Capital's biggest Q4 2021 reduction was Enterprise Products Partners, cutting an estimated $673K.
  • Fore Capital fully exited U.S. Equity Ex-Dividends Fund - Series 2027 in Q4 2021, selling an estimated $14.5M.
  • Fore Capital's ten largest holdings make up 78% of its $294M portfolio in Q4 2021.
  • Fore Capital opened 15 new positions and closed 20 in Q4 2021.
  • Fore Capital's portfolio value rose 51% quarter-over-quarter to $294M.

Based on Fore Capital's 13F filing for Q4 2021, filed 11 Feb 2022.